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Table 
Group 1 (n = Group 2 (n = Group 3 (n = Group 4 (n = p 
226) 1065) 427) 73) value 
TIMI 3 post 93.4 91.3 86.9 90.4 0.012 
(%) 
30-day 
death 
3.1 2.5 5.6 9.6 0.001 
Conclusion. Our study shows that time-to-reperfusion is a prognostic determinant of out- 
come in patients with STEMI treated with primary angioplasty. Thus, all efforts (an early 
diagnosis and a rapid transportation to an angioplasty center)should be done to revascu- 
larize patients with STEMI within 4 hours after symptom onset. 
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827-4 Multiple Lesion Coronary Intervention Is Associated 
With Higher Mortality in Primary Angioplasty for Acute 
Myocardial Infarction: The Stent PAMI Trial 
Greaorv G. Pellizzon, Kishore Harjai. Srinivas Addala, Anthony Ochoa, Gregg W. Stone, 
David A. Cox, Lorelei Grines, Judith A. Boura, Bruce R. Brodie. William W. O’Neill, Cindy 
L. Grines, William Beaumont Hospital, Royal Oak, MI 
Background: The optimal revascularization strategy for patients with acute myocardial 
infarction (AMI) found to have multiple lesions dung primary percutaneous coronary 
!ntervention (PCI) remains unknown. We determined the safety of revascularizing a non- 
culprit lesion (NCL) during primary PCI for AMI. 
Methods: We examined 473 AMI patients undergoing pnmary PCI who had a NCL 
(defined as z 50% angiographic stenosis). We compared angiographic and clinical out- 
comes in patients in whom the NCL was treated during primary PCI (group A, N=lOl) 
versus patients whose NCL was left untreated (group B, N=372). 
Results: Initial and final TIMI 3 flow and ejection fraction were similar. Group A patients 
had less multivessel disease (pcO.0001) but more diseased segments in the infarct 
related artery (IRA) (p-zO.0001). All but 2 patients had NCL intervention performed within 
the IRA. Outcomes for group A and group B were similar; at 1 year, reinfarction (3% vs. 
4.3%) and ischemic TVR (16% vs. 18%) and total revascularization (37% vs. 34%) were 
slmllar. Group A patients had a higher total mortality at 1 year (9.9% vs. 4.3%, pzO.029) 
and a trend to higher cardiac mortality (6% vs. 3.5%, ~~0.26). By multivariate analysis, 
treatment of NCL remamed an independent predictor of total mortality at 1 year (OR 
3.03, p=O.OOSS). Conclusion: Multiple lesion PCI is safe acutely but associated with 
greater late mortality in patients undergoing primary PCI for AMI. These data suggest 
avoiding treatment of the NCL in the IRA 
S!i 
827-5 
5:oo pm 
No Mortality Benefit of Primary Angioplasty Over 
Thrombolytic Therapy in Patients With Nonanterior 
Myocardial Infarction at Long-Term Follow-Up: Results 
of the Zwolle Trial 
Arnoud W. van ‘t Hof , Jose Henriques, Jan-Paul Ottervanger, Jan Henk Dambrmk, 
Marcel Gosselink, Jan C. Hoorntje. Menko Jan de Boer, Felix Zijlstra, lsala Klinieken, lx 
Weezenlanden, Zwolle, The Netherlands 
Background. Primary angioplasty (PA) has been shown to be an effective reperfusion 
therapy in pts with acute myocardial Infarction (AMI). However, only few studies specifi- 
cally addressed the extent of benefit over thrombolytic therapy according to infarct loca- 
tion. 
Methods. From 1990 to 1995, 395 pts with AMI were randomized to i.v. streptokinase 
(SK) or PA at our center.244 (62%) pts had non-anterior MI. defined as ST elevation of 1 
mm in at least 2 contiguous inferw leads. Follow-up information was obtained in Sep- 
tember 2000. Survival was calculated by the Kaplan-Meler pruduct-limit method. The log 
rank test was used to evaluate differences in survival. 
Results. During a median of 8 yr follow-up, a total of 105 pts died (26.5%). Kaplan-Meier 
survival curves are shown in the figure. For the combined incidence of death and re-inf- 
arction (re-MI), PA was superior to SK for both anterior and non-antenor Ml (Non-Ant 
PA:28/117 (23.9%); SK:50/127 (39.4%). P<O.Ol, Ant: PA: 25177 (32.5%);SK:44/74 
(59.5%). p.z0.001). 
Conclusion. A large mortality benefit was found in pts with anterior Ml treated with PA 
compared to SK. For pts with non-anterior MI no difference in mortality was found at long 
term follow-up. For the combined incidence of death and ra MI, PA was superior to SK for 
both anterior and non-anterior Ml. 
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827-6 Randomized Trial of Primary Angioplasty Versus 
Prehospital Hibrinolysis in Acute Myocardial Infarction: 
One-Year Survival Results 
Alain Leizorovicz, Paul Touboul, Eric Bonnefoy, Oliwer Piegay, CAPTIM Group, School 
of Medrcine RTH Laennec, Lyon, France 
Background 
Prehospital fibrinolysis and primary angioplasty have been shown to provide a clinical 
benefit over in-hospital fibrinolysis in acute myocardial infarction (AMI) We did a ran- 
domized trial to compare directly these strategies on clinically r&vent outcomes, cardio- 
vascular events and mortality at short term and long term mortality. 
Methods 
Patients who presented within 6 hours of acute ST-segment elevation myocardial infarc- 
tion, initially managed by mobile emergency care unit personnel, were randomized to 
prehospital fibrinolysis (n=419) with accelerated alteplase (e-PA) or to primary angio- 
plasty (n=421) All were transferred to a centre with access to emergency angioplasty. 
The primary endpoint was a composite of death, nonfatal reinfarction. and nonfatal dis- 
abling stroke at 30 days. Secondary endpoints included total death at 30 days, at one 
year and at a common cut off date, one year after the lnclus~on of the last patient. 
Results 
The incidence of the primary endpoint (already reported) in the prehospital fibrinolysis 
and primary angloplasty groups was 8.2% and 6.2% respectively (p = 0.29). 
Death at 30 Days occurred in 3.8% of the patients assigned to prehospital fibrinolysis 
and 4.8% of those assigned to primary angioplasty (P=O.61). 
Total mortalty 
Angioplasty RR (95% Cl) P value 
Fibrinolysis 
End of follow up 28/419 (6.7%) 371421 (8.8%) 1.31 (0.82 ; 2.11) 0.25 
One year 221408 (5.4%) 30/412 (7.3%) 1.35 (0.79 ; 2.30) 0.27 
Conclusion 
In this low risk AMI population, the long term mortality results confirm the trends already 
observed at 30 days with no clear major advantage of primary angioplasty over pre-hos- 
pital fibrinolysis in terms of survival. 
